197 related articles for article (PubMed ID: 22178756)
21. Roles of mitogen-activated protein kinase and phosphoinositide 3'-kinase in ErbB2/ErbB3 coreceptor-mediated heregulin signaling.
Vijapurkar U; Kim MS; Koland JG
Exp Cell Res; 2003 Apr; 284(2):291-302. PubMed ID: 12651161
[TBL] [Abstract][Full Text] [Related]
22. Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal.
Chiche A; Moumen M; Petit V; Jonkers J; Medina D; Deugnier MA; Faraldo MM; Glukhova MA
Stem Cells; 2013 Sep; 31(9):1857-67. PubMed ID: 23712598
[TBL] [Abstract][Full Text] [Related]
23. Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis.
Smirnova T; Zhou ZN; Flinn RJ; Wyckoff J; Boimel PJ; Pozzuto M; Coniglio SJ; Backer JM; Bresnick AR; Condeelis JS; Hynes NE; Segall JE
Oncogene; 2012 Feb; 31(6):706-15. PubMed ID: 21725367
[TBL] [Abstract][Full Text] [Related]
24. Basal but not luminal mammary epithelial cells require PI3K/mTOR signaling for Ras-driven overgrowth.
Plichta KA; Mathers JL; Gestl SA; Glick AB; Gunther EJ
Cancer Res; 2012 Nov; 72(22):5856-66. PubMed ID: 23010075
[TBL] [Abstract][Full Text] [Related]
25. Heregulin-ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells.
Yarar D; Lahdenranta J; Kubasek W; Nielsen UB; MacBeath G
Mol Cancer Ther; 2015 Sep; 14(9):2072-80. PubMed ID: 26116360
[TBL] [Abstract][Full Text] [Related]
26. Regulation of mammary gland branching morphogenesis by EphA2 receptor tyrosine kinase.
Vaught D; Chen J; Brantley-Sieders DM
Mol Biol Cell; 2009 May; 20(10):2572-81. PubMed ID: 19321667
[TBL] [Abstract][Full Text] [Related]
27. Cell cycle activation in lung adenocarcinoma cells by the ErbB3/phosphatidylinositol 3-kinase/Akt pathway.
Sithanandam G; Smith GT; Masuda A; Takahashi T; Anderson LM; Fornwald LW
Carcinogenesis; 2003 Oct; 24(10):1581-92. PubMed ID: 12896906
[TBL] [Abstract][Full Text] [Related]
28. The ErbB3 receptor tyrosine kinase negatively regulates Paneth cells by PI3K-dependent suppression of Atoh1.
Almohazey D; Lo YH; Vossler CV; Simmons AJ; Hsieh JJ; Bucar EB; Schumacher MA; Hamilton KE; Lau KS; Shroyer NF; Frey MR
Cell Death Differ; 2017 May; 24(5):855-865. PubMed ID: 28304405
[TBL] [Abstract][Full Text] [Related]
29. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer.
Gastaldi S; Sassi F; Accornero P; Torti D; Galimi F; Migliardi G; Molyneux G; Perera T; Comoglio PM; Boccaccio C; Smalley MJ; Bertotti A; Trusolino L
Oncogene; 2013 Mar; 32(11):1428-40. PubMed ID: 22562252
[TBL] [Abstract][Full Text] [Related]
30. Alternate paths from epidermal growth factor receptor to Akt in malignant versus nontransformed lung epithelial cells: ErbB3 versus Gab1.
Sithanandam G; Smith GT; Fields JR; Fornwald LW; Anderson LM
Am J Respir Cell Mol Biol; 2005 Nov; 33(5):490-9. PubMed ID: 16055672
[TBL] [Abstract][Full Text] [Related]
31. Flotillin depletion affects ErbB protein levels in different human breast cancer cells.
Asp N; Pust S; Sandvig K
Biochim Biophys Acta; 2014 Sep; 1843(9):1987-96. PubMed ID: 24747692
[TBL] [Abstract][Full Text] [Related]
32. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
33. Growth defects induced by perturbation of beta1-integrin function in the mammary gland epithelium result from a lack of MAPK activation via the Shc and Akt pathways.
Faraldo MM; Deugnier MA; Thiery JP; Glukhova MA
EMBO Rep; 2001 May; 2(5):431-7. PubMed ID: 11375936
[TBL] [Abstract][Full Text] [Related]
34. A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.
Lee H; Akita RW; Sliwkowski MX; Maihle NJ
Cancer Res; 2001 Jun; 61(11):4467-73. PubMed ID: 11389077
[TBL] [Abstract][Full Text] [Related]
35. c-Jun N-terminal kinase activity supports multiple phases of 3D-mammary epithelial acinus formation.
McNally S; McArdle E; Gilligan E; Napoletano S; Gajewska M; Bergin O; McCarthy S; Whyte J; Bianchi A; Stack J; Martin F
Int J Dev Biol; 2011; 55(7-9):731-44. PubMed ID: 22161830
[TBL] [Abstract][Full Text] [Related]
36. The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation.
Holbro T; Beerli RR; Maurer F; Koziczak M; Barbas CF; Hynes NE
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8933-8. PubMed ID: 12853564
[TBL] [Abstract][Full Text] [Related]
37. Heregulin-induced VEGF expression via the ErbB3 signaling pathway in colon cancer.
Yonezawa M; Wada K; Tatsuguchi A; Akamatsu T; Gudis K; Seo T; Mitsui K; Nagata K; Tanaka S; Fujimori S; Sakamoto C
Digestion; 2009; 80(4):215-25. PubMed ID: 19797898
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells.
Sivaprasad U; Fleming J; Verma PS; Hogan KA; Desury G; Cohick WS
Endocrinology; 2004 Sep; 145(9):4213-21. PubMed ID: 15192040
[TBL] [Abstract][Full Text] [Related]
39. Epithelial-to-mesenchymal transition rewires the molecular path to PI3K-dependent proliferation.
Salt MB; Bandyopadhyay S; McCormick F
Cancer Discov; 2014 Feb; 4(2):186-99. PubMed ID: 24302555
[TBL] [Abstract][Full Text] [Related]
40. Signaling events mediated by α3β1 integrin are essential for mammary tumorigenesis.
Cagnet S; Faraldo MM; Kreft M; Sonnenberg A; Raymond K; Glukhova MA
Oncogene; 2014 Aug; 33(34):4286-95. PubMed ID: 24077284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
